Antiarrhythmics in atrial fibrillation

Bethan Freestone, Gregory Lip

Research output: Contribution to journalReview article


Atrial fibrillation (AF) is a common arrhthymia that exists in both the acute and chronic form. As the molecular basis of arrhythmogenesis is further elucidated, the discovery of novel antiarrhythmic agents, which can be tailored to individual patients and the particular subtype of AF, while minimizing potential side effects, will become possible.
Original languageEnglish
Pages (from-to)84-88
Number of pages5
JournalCurrent Opinion in Investigational Drugs
Publication statusPublished - 1 Jan 2001


Dive into the research topics of 'Antiarrhythmics in atrial fibrillation'. Together they form a unique fingerprint.

Cite this